BioCentury
ARTICLE | Clinical News

Viramune nevirapine: Phase IIIb started

May 14, 2007 7:00 AM UTC

The company began the open-label, international Phase IIIb ArTEN trial in 561 treatment-naïve HIV patients to compare once- or twice-daily Viramune plus tenofovir to once-daily atazanavir/ritonavir pl...